Form 4: Herbalife Director Celine Del Genes Reports Acquisition of Restricted Stock Units

Director Celine Del Genes reports acquisition of 15,657 restricted stock units in Herbalife Ltd.

Summary

• Celine Del Genes, a director of Herbalife Ltd., filed a Form 4 with the SEC.
• The filing reports a transaction on May 3, 2024, where Ms. Del Genes acquired 15,657 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs were granted under the Herbalife Ltd. 2023 Stock Incentive Plan.
• The RSUs will vest 100% on April 15, 2025, contingent upon continued service on the Issuer's Board of Directors.
• Following the reported transaction, Ms. Del Genes beneficially owns 33,961 shares of Herbalife Ltd. common stock directly.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock ownership. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Future Outlook

The RSUs will vest on April 15, 2025, subject to continued service on the Issuer's Board of Directors.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, such as directors and officers, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value.

Key Dates